For example, dovitinib, a novel multi-target receptor tyrosine kinase inhibitor enrolled in several clinical trials in different cancers, was shown to induce autophagic cell death and apoptosis in several breast cancer cell lines including MDA-MB-231 (36). The gene discussed is NTRK1; the disease is breast carcinoma.